$BFLY

DEVIVO JOSEPH sold $1.6M of BFLY

DEVIVO JOSEPH (President & CEO) sold 204,725 shares of Butterfly Network, Inc. (BFLY) at $7.87 ($1.61M total) on 2026-07-07.

Original reporting
SEC EDGAR · DEVIVO JOSEPH
Published Jul 8, 2026, 8:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BFLY
Neutral
high confidence
Mentioned
$BFLY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

The CEO’s open-market sale may slightly affect sentiment, but it does not introduce new operational or financial information.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to change valuation drivers.

03

What to watch

No 10b5-1 plan is stated, but the article does not provide motives, other concurrent transactions, or whether sales were part of a broader compensation/tax schedule.

Relevance 6/10Novelty 3/10Timing: Filed 2026-07-08, covering a sale executed 2026-07-07.

Background

The article is an SEC Form 4 insider transaction disclosure for Butterfly Network, Inc.

Company-level read

Ticker impact

$BFLYNeutralHigh confidence
Context

SEC Form 4 shows Butterfly Network CEO Joseph Devivo sold 204,725 shares on 2026-07-07 for about $1.61M.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing provides transaction size, price, and post-sale holdings, but no new guidance, contracts, litigation, or operational change.

Market effects

Minimal, as the disclosure is company-specific insider trading without sector-wide information.

None indicated.

None indicated.

Counterpoint

Insider sales can be for diversification, taxes, or planned liquidity needs, so the signal may be weak without follow-on context.

Key entities

  • Butterfly Network, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • DEVIVO JOSEPH

    President and CEO who sold 204,725 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.

$BFLYHigh

Evercore ISI initiates Butterfly Network stock with outperform rating

Evercore ISI initiated coverage on Butterfly Network (NYSE: BFLY) with an outperform rating and $15.00 price target, citing its ultrasound-on-chip technology and growth potential. The firm projects $550M+ revenue by 2030 and positive EBITDA by 2028. BFLY stock has risen 367% over the past year, trading at $9.15 with a $2.44B market cap. Q2 2026 results showed a smaller loss than expected but lower revenue. Needham also initiated coverage with a buy rating and $10.00 target.

$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong